3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Glioblastoma
13
Brain Neoplasms
12
Neuroblastoma
11
Gliosarcoma
7
Astrocytoma
7
Oligodendroglioma
5
Glioma
5
Medulloblastoma
4
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Wilms Tumor
2
Spinal Cord Neoplasms
2
Rhabdoid Tumor
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Optic Nerve Glioma
2
Lung Neoplasms
2
Familial ependymoma
2
Diffuse Intrinsic Pontine Glioma
2
Dendritic Cell Sarcoma, Interdigitating
2
Choroid Plexus Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
Cyclophosphamide
8
Temozolomide
6
Topotecan
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
X-Rays
4
Phantoms, Imaging
4
Irinotecan
4
palbociclib
3
fludarabine
3
Vincristine
3
Specimen Handling
3
Sirolimus
3
Magnetic Resonance Spectroscopy
3
Busulfan
3
Bone Marrow Transplantation
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
ivosidenib
2
irinotecan sucrosofate
2
cabozantinib
2
abemaciclib
2
Zoledronic Acid
2
Vemurafenib
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vorinostat
×
CNS
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled